Skip to main content
. 2019 Nov 29;19(1):665–671. doi: 10.3892/etm.2019.8257

Figure 2.

Figure 2.

Network diagram of evidence for treatment efficacy of each regimen. The size of each node is proportional to the sample size of the individual treatment regimen; the widths of the connecting lines are proportional to the number of studies compared between the two regimens. GC, glucocorticoid; CTX, cyclophosphamide; MMF, mycophenolate; TAC, tacrolimus; LEF, leflunomide; RTX, rituximab; CsA, cyclosporine A.